Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

Metformin Hydrochloride Prolonged Release And Glimepiride Tablets Ip

₹ 170/StripGet Latest Price

Packaging Size10*10 Tablets
Pack TypeBox
Pack Size10*10 Tablets
ManufacturerChemo Life Cure
Usage / ApplicationType 2 diabetes
Shelf Life2 years
AvailabilityIn Stock
View in Hindi मेटफॉर्मिन हाइड्रोक्लोराइड प्रोलंग्ड रिलीज और ग्लिमेपिराइड टैबलेट्स आईपी

GLIMREM-GM2 Tablet is a combination of glimepiride, metformin, and pioglitazone. It is used to control blood sugar levels in adults with type 2 diabetes when diet, exercise, and single-agent therapy are insufficient.

Shipping Information

PriceExcluding all taxes
Ships fromSonipat
ShippingAs per delivery location

Product Image

Metformin Hydrochloride Prolonged Release And Glimepiride Tablets Ip-1Metformin Hydrochloride Prolonged Release And Glimepiride Tablets Ip-2Metformin Hydrochloride Prolonged Release And Glimepiride Tablets Ip-3

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
24-04-2024
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
40 L - 1.5 Cr
IndiaMART Member Since
June 2024
GST
06ABQPO3074M1Z2

Established in the year of 2024, we “Chemo Life Cure” are Trader,Wholesaler And Distributor of Pharmaceutical Tablets, Pharmaceutical Capsules, Pharmaceutical Injection, Pcd Pharma Franchise, Ayurvedic Syrup, Dry Syrup, Eye Drops, Acetylcysteine Tablet, Protein Powder, Hand Sanitizer Spray etc We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our (CEO) “Mr.Rishab Kumar Ostawal” whose continual backing and direction have been useful to us for attaining exponential development in the current market